![]() “COVID-19 vaccine safety is a top priority for the federal government and we take all reports of adverse events following vaccination seriously.”Īs of April 12, more than 6.8 million doses of the Johnson and Johnson vaccine have been administered and the CDC and FDA are currently investigating the matter further to provide guidance not only to health professionals, but for current recipients of the Johnson and Johnson COVID-19 vaccine. “Right now, I like to stress these events appear to be extremely rare,” Woodcock states. Janet Woodcock, MD, acting FDA commissioner stresses in a CDC and FDA joint media call that adverse reactions to vaccines are extremely rare and the advisory reflects the CDC and FDA’s abundance of caution they have around vaccine safety. Today, the CDC and FDA released a recommendation to pause the distribution of the Johnson and Johnson vaccine in the United States due to reported cases of a rare blood clot called cerebral venous sinus thrombosis (CVST) linked to low platelet counts following vaccination. UPDATE: As of Friday, April 23, the CDC and FDA approved the J&J vaccine for use again, after an 11 day pause. Looking for more information on all COVID vaccines and diabetes? Click here. Visit to learn more about what you can do as a person with diabetes to keep yourself and others safe from COVID-19 until we’re all safe. Learn more about: Tracking COVID-19 and COVID-19 trends.Editor’s Note: We have a simple goal: tap into the power of the global diabetes community to save lives. Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date.įor more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and. To learn about Mayo's recommendations for the public, check the COVID-19 information on. Visit the COVID-19 Information Center for more resources, including answers to FAQs regarding the safety, eligibility, availability and timing of COVID-19 vaccines. Note: Experiencing mild to moderate headache and muscle aches are common in the first 3 days after vaccination and do not require emergency care.ĭoes this affect the Pfizer and Moderna vaccines?Įvidence of this rare clotting disorder has not been reported in either the Pfizer and Moderna vaccines. If you have received the Johnson & Johnson COVID-19 vaccine in the last three weeks and are experiencing unexplained new severe symptoms between three days to three weeks after vaccination, such as new severe headaches, leg pain, abdominal pain or shortness of breath, you should seek emergency care. The six cases involved women between ages 18 and 48 and occurred 6 to 13 days after vaccination. This rare blood clotting reaction has occurred in 6 people out of nearly 7 million people who have received the Johnson & Johnson vaccine. What should patients who have received Johnson & Johnson do at this time? Mayo Clinic is committed to patient safety and will take the time required to understand more about the evolving situation. Based on that evaluation and recommendation the FDA and CDC may communicate their findings and next steps regarding this pause. ACIP is an independent immunization advisory group for the federal government agencies. The Advisory Committee on Immunization Practices (ACIP) is meeting Wednesday, April 14, to evaluate and review the data from the rare adverse event cases reported so far. While a review is underway to address next steps, the FDA and CDC are asking health care providers to watch for, evaluate and report cases. Out of an abundance of caution, the FDA and CDC recommends a pause on the Johnson & Johnson vaccine based on six rare blood clotting events in recipients. Why is the FDA and CDC recommending a pause on distributing the Johnson & Johnson vaccine? Mayo Clinic in Arizona and Florida did not administer the Johnson & Johnson vaccine. This pause affects only Mayo Clinic locations in the Midwest. ![]() As a result, Mayo Clinic will follow this guidance and pause on delivering the Johnson & Johnson vaccine until further notice. On Tuesday, April 13, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) announced a joint recommendation to pause distribution of the Johnson & Johnson vaccine after reported cases of rare blood clotting events in recipients.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |